eMagin Registers 14% Revenue Growth In Q2 Aided By Military Programs; Expands Margin

  • eMagin Corp EMAN reported second-quarter FY22 revenue growth of 14% year-on-year to $7.2 million, missing the consensus of $7.36 million.
  • Segments: Product revenue rose 22.4% Y/Y to $7.03 million primarily due to the timing of specific orders from military markets and shipments under its ENVG-B program.
  • Due to higher product revenues, the gross margin expanded by 1,300 bps to 22%.
  • The operating loss improved by 38.4% Y/Y to $(1.8) million. 
  • EPS loss was $(0.02).
  • eMagin held $4.3 million in cash and equivalents.
  • CEO Andrew G. Sculley said, "We achieved continued growth in display revenue from the ENVG-B program and other military programs and increased veterinary and surgical revenues. Also, in the second quarter, we strengthened our relationship with a major prime contractor by advancing our capabilities for higher-level assembly and shipped displays to a customer providing heads-up displays for optical surgery."
  • Price Action: EMAN shares traded higher by 5.52% at $0.87 in the premarket session on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Posted In: EarningsNewsPenny StocksTechBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!